1. Home
  2. JCSE vs EVAX Comparison

JCSE vs EVAX Comparison

Compare JCSE & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo JE Cleantech Holdings Limited

JCSE

JE Cleantech Holdings Limited

N/A

Current Price

$1.20

Market Cap

5.9M

ML Signal

N/A

EVAX

Evaxion Biotech

N/A

Current Price

$6.06

Market Cap

42.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
JCSE
EVAX
Founded
1999
2008
Country
Singapore
Denmark
Employees
N/A
N/A
Industry
Miscellaneous manufacturing industries
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.9M
42.7M
IPO Year
2022
2021

Fundamental Metrics

Financial Performance
Metric
JCSE
EVAX
Price
$1.20
$6.06
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$12.33
AVG Volume (30 Days)
5.5K
98.3K
Earning Date
10-30-2025
11-06-2025
Dividend Yield
8.26%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$11,804,296.00
$7,650,000.00
Revenue This Year
N/A
$128.77
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
132.17
52 Week Low
$0.86
$1.20
52 Week High
$1.75
$12.15

Technical Indicators

Market Signals
Indicator
JCSE
EVAX
Relative Strength Index (RSI) 43.05 50.91
Support Level $1.10 $5.72
Resistance Level $1.28 $6.70
Average True Range (ATR) 0.03 0.50
MACD 0.00 0.04
Stochastic Oscillator 0.00 44.97

Price Performance

Historical Comparison
JCSE
EVAX

About JCSE JE Cleantech Holdings Limited

JE Cleantech Holdings Ltd is engaged in the manufacturing and selling of cleaning systems and other equipment that can be categorized into four different categories, namely aqueous washing systems, plating and cleaning systems, train cleaning systems, and other equipment, such as filtration units. The product lives of its cleaning systems and other equipment ranges from two to ten years. The company is also into designing, developing, and manufacturing other cleaning systems for various industrial end-use applications using its R&D and engineering capabilities. The company derives the majority of its revenue from the Sales of cleaning systems and other equipment. Geographically, the company derives a majority of its revenue from Singapore, followed by Malaysia.

About EVAX Evaxion Biotech

Evaxion AS is a techBio company based on its AI platform, AI-Immunology. Evaxion's proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing innovative and targeted treatment options.

Share on Social Networks: